Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Interest Income Expense
Fusion Antibodies PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Interest Income Expense
£4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Interest Income Expense
£18.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
162%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Interest Income Expense
£569k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Interest Income Expense
-£9k
|
CAGR 3-Years
67%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Interest Income Expense
-£1.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Interest Income Expense
£1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Interest Income Expense?
Interest Income Expense
4k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Interest Income Expense amounts to 4k GBP.
What is Fusion Antibodies PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-10%